Pages that link to "Q42213423"

The following pages link to Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent (Q42213423):

Displaying 34 items.

• Next-generation antimicrobials: from chemical biology to first-in-class drugs (Q26799749) (← links)
• Endless Resistance. Endless Antibiotics? (Q28822179) (← links)
• Antibiotics in the clinical pipeline at the end of 2015. (Q30249262) (← links)
• Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection. (Q33913678) (← links)
• Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents (Q35844546) (← links)
• Turning the respiratory flexibility of Mycobacterium tuberculosis against itself (Q37181195) (← links)
• Future target-based drug discovery for tuberculosis? (Q38280137) (← links)
• The anti-tuberculosis agents under development and the challenges ahead (Q38617197) (← links)
• Synthetic investigational new drugs for the treatment of tuberculosis (Q38635790) (← links)
• Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions (Q38672958) (← links)
• New structural classes of antituberculosis agents (Q39362128) (← links)
• One-Pot Synthesis of Benzo[4,5]imidazo[2,1-a]isoquinolines and Isoquinolino[3,4-b]quinoxalines via Tandem Cyclization Strategies. (Q39876040) (← links)
• Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds. (Q40156484) (← links)
• Base-Free Photoredox/Nickel Dual-Catalytic Cross-Coupling of Ammonium Alkylsilicates (Q40911543) (← links)
• Identification of N-(2-Phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as New Antituberculosis Agents (Q46251938) (← links)
• Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids. (Q50205820) (← links)
• Cu(OAc)2-Et3N mediated oxidative coupling of α-azido ketones with pyridinium ylides: utilizing in situ generated imines for regioselective synthesis of imidazo[1,2-a]pyridines (Q50271627) (← links)
• Synthesis of Novel Imidazo[1,2-a]pyridin-2-amines from Arylamines and Nitriles via Sequential Addition and I2 /KI-Mediated Oxidative Cyclization. (Q50858609) (← links)
• Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels. (Q52597961) (← links)
• Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery. (Q52688603) (← links)
• In vitro and ex vivo antitubercular activity of diarylheptanoids from the rhizomes of Alpinia officinarum Hance. (Q53162866) (← links)
• Rapid, metal-free and aqueous synthesis of imidazo[1,2-a]pyridine under ambient conditions (Q56333421) (← links)
• Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis (Q57291166) (← links)
• One-pot, three component tandem reaction of 2-aminopyridines, acetophenones and aldehydes: synthesis of 3-aroylimidazo[1,2-a]pyridines (Q58200668) (← links)
• Targeting the Mycobacterium ulcerans cytochrome bc:aa for the treatment of Buruli ulcer (Q60020041) (← links)
• Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB (Q89257069) (← links)
• Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis (Q90068138) (← links)
• Antibiotics in the clinical pipeline in October 2019 (Q90171597) (← links)
• Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease (Q90914855) (← links)
• Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening (Q91776789) (← links)
• New tuberculosis drug targets, their inhibitors, and potential therapeutic impact (Q91807571) (← links)
• Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds (Q92439445) (← links)
• Opportunities for Overcoming Mycobacterium tuberculosis Drug Resistance: Emerging Mycobacterial Targets and Host-Directed Therapy (Q92854360) (← links)
• Current advances in the clinical development of anti-tubercular agents (Q99590353) (← links)